Vistagen Therapeutics, Inc. — SC 13G/A Filings
35 SC 13G/A filings on record
This page lists all SC 13G/A filings submitted to the SEC by Vistagen Therapeutics, Inc. (VTGN), sorted by most recent first. Each row links to the full filing on EdgarLookup. Vistagen Therapeutics, Inc. has filed 35 SC 13G/A documents with the SEC since 2007. To view all SEC filings by Vistagen Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
10KSB
10QSB
3
3/A
4
4/A
424B3
424B4
424B5
5
8-A12B
8-A12G
8-K
8-K/A
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
EFFECT
FWP
NT 10-K
NT 10-Q
POS AM
PRE 14A
PRER14A
RW
S-1
S-1/A
S-3
S-3/A
S-8
S-8 POS
SB-2
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC 14F1
SC 14F1/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G/A | — | 0001172661-24-005308 | Nov 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-118974 | Nov 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-024115 | Feb 14, 2024 | — |
| SC 13G/A | — | 0001172661-24-001528 | Feb 14, 2024 | — |
| SC 13G/A | VISTAGEN THERAPEUTICS, INC. | 0000902664-24-001585 | Feb 14, 2024 | — |
| SC 13G/A | — | 0001493152-23-036493 | Oct 6, 2023 | — |
| SC 13G/A | — | 0001306550-23-009518 | Jul 7, 2023 | — |
| SC 13G/A | AMENDMENT NO. 2 | 0000947871-23-000193 | Feb 14, 2023 | — |
| SC 13G/A | — | 0001493152-23-004860 | Feb 14, 2023 | — |
| SC 13G/A | — | 0000935836-23-000252 | Feb 14, 2023 | — |
| SC 13G/A | — | 0001306550-23-006401 | Feb 1, 2023 | — |
| SC 13G/A | SC 13G/A | 0001104659-22-078364 | Jul 8, 2022 | — |
| SC 13G/A | — | 0000935836-22-000196 | Feb 15, 2022 | — |
| SC 13G/A | SC 13G/A | 0001104659-22-022889 | Feb 14, 2022 | — |
| SC 13G/A | AMENDMENT NO. 1 | 0000947871-22-000218 | Feb 11, 2022 | — |
| SC 13G/A | SC 13G/A | 0001019056-21-000055 | Jan 22, 2021 | — |
| SC 13G/A | SC 13G/A | 0001178913-20-000343 | Feb 11, 2020 | — |
| SC 13G/A | SC 13G/A | 0001178913-19-000442 | Feb 13, 2019 | — |
| SC 13G/A | AMENDMENT NO. 2 TO SCHEDULE 13G | 0001213900-19-001922 | Feb 8, 2019 | — |
| SC 13G/A | SABBY 13G-A VTGN 1.03.19 | 0001535610-19-000010 | Jan 3, 2019 | — |
| SC 13G/A | SC 13G/A | 0001178913-18-000511 | Feb 13, 2018 | — |
| SC 13G/A | AMENDMENT NO. 1 TO FORM SC 13G | 0001213900-18-001636 | Feb 13, 2018 | — |
| SC 13G/A | SC 13G/A | 0001104659-18-007917 | Feb 9, 2018 | — |
| SC 13G/A | VISTAGEN THERAPEUTICS, INC. | 0000902664-18-000161 | Jan 12, 2018 | — |
| SC 13G/A | SABBY 13G-A VTGN 1.09.18 | 0001535610-18-000054 | Jan 9, 2018 | — |
| SC 13G/A | VISTAGEN THERAPEUTICS, INC. | 0000902664-17-000498 | Jan 27, 2017 | — |
| SC 13G/A | SC 13G/A | 0001178913-17-000153 | Jan 24, 2017 | — |
| SC 13G/A | SABBY 13G-A VTGN 1.10.17 | 0001535610-17-000045 | Jan 10, 2017 | — |
| SC 13G/A | — | 0001415889-16-006352 | Jul 1, 2016 | — |
| SC 13G/A | MAY 23, 2016 | 0001013594-16-001064 | May 24, 2016 | — |
| SC 13G/A | FEBRUARY 18, 2015 | 0001013594-15-000150 | Feb 18, 2015 | — |
| SC 13G/A | FEBRUARY 17, 2015 | 0001013594-15-000143 | Feb 17, 2015 | — |
| SC 13G/A | PLATINUM LONG TERM GROWTH VII, LLC SC 13G A NO 3 12-31-2013 (VISTAGEN THERAPEUTI | 0001140361-14-007426 | Feb 14, 2014 | — |
| SC 13G/A | PLATINUM LONG TERM GROWTH VII, LLC SC 13G A 12-31-2012 | 0001140361-13-007633 | Feb 15, 2013 | — |
| SC 13G/A | PLATINUM LONG TERM GROWTH VII, LLC SC 13G A 12-31-2011 | 0001140361-12-002137 | Jan 12, 2012 | — |